Goodwin Procter has advised Jefferies LLC, Jefferies GmbH, TD Cowen, Stifel, Nicolaus & Company, Incorporated, Stifel Europe Securities, Van Lanschot Kempen (USA) Inc., and Van Lanschot...
Valneva Completes €84 Million Private Placement
Apnimed Secures $150 Million Debt Financing and Monetizes SASS Joint Venture Stake
Hogan Lovells has advised HealthCare Royalty Partners. Goodwin has advised Apnimed, Inc. Apnimed, Inc., a pharmaceutical company focused on developing oral therapies for obstructive sleep apnea...
ARCHIMED Acquires Esperion Therapeutics in $1.1 Billion Transaction
Sidley Austin and Moelis & Company have advised ARCHIMED. Goodwin Procter and Centerview Partners have advised Esperion Therapeutics. Akin Gump has advised Pharmakon Advisors. ARCHIMED, a...
Novartis Acquires Pikavation Therapeutics and PI3K? Inhibitor Portfolio from Synnovation for Up to $3 Billion
Goodwin Procter and Mintz have advised Synnovation Therapeutics on the transaction. Novartis has entered into a definitive agreement to acquire Pikavation Therapeutics, Inc., a wholly-owned subsidiary...
Candel Therapeutics Completes $100 Million Public Offering and Secures Royalty Funding Agreement
Goodwin has advised Candel Therapeutics, Inc. Paul Hastings LLP has advised Citigroup, Cantor and Stifel as joint bookrunning managers. Candel Therapeutics, Inc. has completed an underwritten...
Prime Medicine Closes $144 Million Public Offering of Common Stock
Goodwin Procter, Foley Hoag, Honigman, and Wilson Sonsini Goodrich & Rosati have advised Prime Medicine Inc. on the offering, and Paul Hastings has advised the underwriters....
Merck’s $3.9 Billion Acquisition of SpringWorks Therapeutics
Sullivan & Cromwell advised Merck KGaA, Darmstadt, Germany, while Goodwin Procter advised SpringWorks Therapeutics on the transaction. Skadden advised Centerview Partners and Goldman Sachs & Co....
Jade Biosciences’ Merger with Aerovate Therapeutics
Gibson, Dunn & Crutcher advised Jade Biosciences on the transaction, and Cooley advised the placement agents; while Goodwin Procter advised Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc....
MBX Biosciences’ $187.7 Million IPO
Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
AVROBIO’s Merger with Tectonic Therapeutic
Leerink Partners is serving as exclusive financial advisor to Tectonic and Cooley LLP is serving as legal counsel to Tectonic. Leerink Partners and TD Cowen are...
LENZ Therapeutics’ Merger with Graphite Bio
Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
Amphastar Pharmaceuticals’ $345 Million Convertible Senior Notes Offering
Goodwin advised the initial purchasers on Amphastar Pharmaceuticals, Inc.’s offering. Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced the Rule 144A offering of 2.00% Convertible Senior Notes due...